Latest news

Professor of cardiovascular and clinical pharmacology and connector Wiek van Gilst knighted

Closing day Leadership Program second group

First group completes two year DCVA Leadership Program

Harteraad Annual report 2021

NHR Annual Report 2021 published

Off to Brussels!

DCVA & RegMedXB Valorisation Community Meeting

Phlox therapeutics closes seed investment round

Leon de Windt: 'Senior researchers are not done developing yet either'

Human Cardiac Tissue available for Cardiovascular Research

Grant for NVVC Connect regions

TargED raises 39 million to bring potential stroke medicine to patients

Check@Home can get started with €3.8 million from NWO

FIRST participates in 1.8 million seed investment for the discovery of two new drugs for heart failure

Collaboration Right Heart Care In The Right Place

ZonMw and the DHF started a new thematic collaboration to facilitate early detection and optimal treatment of atrial fibrillation and heart failure through network care. In Q1 of 2022 two support programs will be lauched.

DCVA Annual Plan 2022

With 2021 at an end, it's time to look forward. What are the plans of the Dutch CardioVascular Alliance in 2022? Find out now!

“Working with others is just more enjoyable”

Professor Wiek van Gilst will be resigning as the DCVA executive chairman. How does he look back on his work and in what way is the establishment of the DCVA the crowning achievement of his career? 

Vision digital cardiovascular healthcare

Last year, seven partners of the DCVA joined forces to develop a vision document about digital cardiovascular healthcare. 

Professor Jolien Roos-Hesselink new managing-director DCVA

Prof. dr. Jolien Roos-Hesselink, a cardiologist affiliated with the Erasmus Medical Center Rotterdam and Radboud University Medical Center Nijmegen, will be the new managing-director of the Dutch CardioVascular Alliance (DCVA). She will succeed Prof. Wiek van Gilst. The supervisory board of the DCVA announced this today.

DCVA Leadership Program 2021-2022